More Articles

Generics policies in Europe have room for improvement Generics/Research | Posted 15/02/2013

In Europe, generics policies have not yet been implemented to their full extent, according to authors Vogler and Zimmerman, reporting on the 2011 Pharmaceutical Pricing and Reimbursement Informatio...

Inequality in Europe over access to biologicals for arthritis Reports | Posted 15/02/2013

Data from a study presented at the European League Against Rheumatism’s Annual European Congress of Rheumatology, EULAR Congress 2012, demonstrates the vast inequalities in access to biologicals fo...

EC accuses J&J and Novartis of delaying generic fentanyl Pharma News | Posted 15/02/2013

On 31 January 2013 the European Commission (EC) sent a statement of objections, to US-based Johnson & Johnson (J&J) and Switzerland-based Novartis accusing them of delayed entry of a generi...

Biosimilars to replace 70% of chemical drugs Biosimilars/General | Posted 15/02/2013

Biosimilars will replace some 70% of global chemical drugs over the next couple of decades, according to industry experts. This replacement will occur due to the better safety profiles of biosimila...

MEPs adopt directive to give quicker access to generics Policies & Legislation | Posted 15/02/2013

Members of the European Parliament (MEPs) have adopted the text of the Transparency Directive 2012/0035(COD) by a large majority in a plenary session of the parliament on 6 February 2013.

AMAC and GPhA hit back at Big Pharma over biosimilars Biosimilars/News | Posted 15/02/2013

The Association of Mature American Citizens (AMAC) and the Generic Pharmaceutical Association (GPhA) have reacted strongly to the actions by Amgen and Genentech, which aim to make it more diff...

Biologicals boom Biosimilars/Research | Posted 15/02/2013

Researchers predict that the present list of top 10 blockbuster drugs will change dramatically by 2014. The predictions are that by 2014 biological drugs will topple the present market leaders Pfiz...

Draft revision of biosimilar low molecular weight heparin guideline Guidelines | Posted 08/02/2013

EMA announced on 31 January 2013 that it had released a draft guideline to revise the agency’s current guideline on biosimilars containing low molecular weight heparins (LMWHs). The draft guideline...